Raphael Mantovani, MBA, PMP
Raphael Mantovani is an experienced professional with over 20 years of experience in strategic project management, business development, and growth plan implementation. With a solid understanding of PMO implementation, financial viability analysis, and marketing analysis, he has successfully spearheaded new company startups, e-commerce launches, and internationalization initiatives. With particular expertise in the pharmaceutical and life sciences industries, he has worked as a professional project manager, equipment qualification expert, process validation specialist, and sales director for both industrial and laboratory equipment.
Mantovani has a deep understanding of running strategic corporate performance and promoting new business and integration between companies, including managing mergers and acquisitions. He is dedicated to promoting growth through digital transformation, innovation, channel diversification, and new business models. He builds strong relationships across regions, working closely with South American executive committee members and global organizational leaders. Mantovani has also founded his own company, FABRATECH, which represents technological solutions for the industry and negotiates international partnerships and deals.
Mantovani has a diverse educational background, including a Leadership Transformation Program & Strategy for Turbulent Times from INSEAD, an MBA in Business Strategy from FIA - Fundação Instituto de Administração, and executive education in Digital Marketing from Insper. He is also certified in various fields, including Project Management from PMI, USA. Additionally, he has led several projects in countries like Argentina, Chile, China, Colombia, Denmark, France, Germany, Mexico, the United States, Panama, Spain, Sweden, and Switzerland.
Overall, Mantovani's skills, knowledge, and extensive experience make him a valuable asset in strategic project management, business development, and growth planning, with particular expertise in the manufacturing, pharmaceutical, and life sciences industries.
